Dr Reddy's Laboratories Ltd (RDY)
71.49
-0.66
(-0.91%)
USD |
NYSE |
Apr 23, 16:00
71.51
+0.02
(+0.03%)
After-Hours: 20:00
Dr Reddy's Laboratories Enterprise Value: 11.23B for April 23, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 11.23B |
| April 22, 2024 | 11.34B |
| April 19, 2024 | 11.17B |
| April 18, 2024 | 11.14B |
| April 17, 2024 | 11.20B |
| April 16, 2024 | 11.25B |
| April 15, 2024 | 11.17B |
| April 12, 2024 | 11.22B |
| April 11, 2024 | 11.43B |
| April 10, 2024 | 11.42B |
| April 09, 2024 | 11.63B |
| April 08, 2024 | 11.60B |
| April 05, 2024 | 11.61B |
| April 04, 2024 | 11.46B |
| April 03, 2024 | 11.49B |
| April 02, 2024 | 11.62B |
| April 01, 2024 | 11.64B |
| March 28, 2024 | 11.54B |
| March 27, 2024 | 11.37B |
| March 26, 2024 | 11.45B |
| March 25, 2024 | 11.55B |
| March 22, 2024 | 11.56B |
| March 21, 2024 | 11.47B |
| March 20, 2024 | 11.45B |
| March 19, 2024 | 11.49B |
| Date | Value |
|---|---|
| March 18, 2024 | 11.90B |
| March 15, 2024 | 11.86B |
| March 14, 2024 | 11.89B |
| March 13, 2024 | 11.86B |
| March 12, 2024 | 12.04B |
| March 11, 2024 | 12.19B |
| March 08, 2024 | 12.08B |
| March 07, 2024 | 12.04B |
| March 06, 2024 | 11.92B |
| March 05, 2024 | 11.95B |
| March 04, 2024 | 11.99B |
| March 01, 2024 | 11.79B |
| February 29, 2024 | 12.11B |
| February 28, 2024 | 12.16B |
| February 27, 2024 | 12.12B |
| February 26, 2024 | 12.16B |
| February 23, 2024 | 12.25B |
| February 22, 2024 | 12.12B |
| February 21, 2024 | 11.92B |
| February 20, 2024 | 11.99B |
| February 16, 2024 | 11.89B |
| February 15, 2024 | 11.82B |
| February 14, 2024 | 11.91B |
| February 13, 2024 | 11.78B |
| February 12, 2024 | 11.90B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.687B
Minimum
Mar 18 2020
12.51B
Maximum
Jul 02 2021
9.319B
Average
9.256B
Median
Jun 15 2023
Enterprise Value Benchmarks
| Concord Medical Services Holdings Ltd | 993.92M |
| ASLAN Pharmaceuticals Ltd | 15.96M |
| Zai Lab Ltd | 693.58M |
| Infosys Ltd | 68.49B |
| SS Innovations International Inc | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 165.60M |
| Revenue (Quarterly) | 866.49M |
| Total Expenses (Quarterly) | 663.45M |
| EPS Diluted (Quarterly) | 0.993 |
| Gross Profit Margin (Quarterly) | 58.50% |
| Profit Margin (Quarterly) | 19.11% |
| Earnings Yield | 5.31% |
| Operating Earnings Yield | 6.62% |
| Normalized Earnings Yield | 5.060 |